Tirzepatide Shows Significant Weight Reduction Benefits in Both Diabetic and Non-Diabetic Patients

Research on the efficacy of tirzepatide in weight management has been published, providing a comprehensive analysis of the medication's effects on patients with and without diabetes. A systematic review and meta-analysis conducted by the Department of Medicine at the University of Evangel Goias in Anapolis, Brazil, compared tirzepatide with placebo in adults with or without diabetes for at least 26 weeks. The study found that tirzepatide resulted in statistically significant and clinically meaningful weight reduction in both patient groups, with a notable difference in the degree of weight loss between the two groups.

Key Takeaways:

  • The study analyzed data from 27 randomized controlled trials, including 4,467 participants with or without diabetes.
  • Tirzepatide was found to be significantly more effective in weight reduction in patients without diabetes, with a relative weight reduction of -9.54% compared to -5.43% in patients with diabetes.
  • The medication led to improved BMI, waist circumference, blood pressure, hemoglobin A1c, and lipid levels in both patient groups.
  • The most common adverse events reported were mild to moderate and well-tolerated.
  • Strata used for analysis included diabetes status and region (Asia vs. non-Asia).
  • Subanalyses were conducted to assess the efficacy and safety of tirzepatide in different subgroups of patients, including those with and without diabetes.

Statistics:

  • 27 randomized controlled trials were analyzed in the study.
  • The number of patients with diabetes in the study was 4,142.
  • The number of patients without diabetes in the study was 1,325.
  • The relative weight reduction with tirzepatide was -9.54% in patients without diabetes.
  • The absolute weight reduction with tirzepatide was around 5.3% in patients without diabetes.

Sources:

  • Effects of Tirzepatide On Weight Management In Patients With and Without Diabetes: a Systematic Review and Meta-analysis. International Journal of Obesity, 2025.
  • Nature Publishing Group - www.nature.com/.
  • International Journal of Obesity - www.nature.com/ijo/.